Myeloid-Mediated Immunoregulation and Resistance to Immune Checkpoint Inhibitor Therapy Across Squamous Cell Carcinomas: Mechanisms and Reprogramming Strategies
Simple Summary Immunotherapy drugs known as immune checkpoint inhibitors have improved outcomes for patients with squamous cell carcinomas of the head and neck, lung, esophagus, and skin, yet most patients still do not respond, even when their tumors look similar at the genetic level. Growing evidence points to a group...